New glycosylsphingolipids from Psychotria serpens L

Nat Prod Res. 2020 Jul;34(14):2095-2100. doi: 10.1080/14786419.2019.1574789. Epub 2019 Feb 19.

Abstract

In clinical, Psychotria serpens L. was often substitute for Caulis trachelospermi to treat cancer in China. Meanwhile, EtOAc and n-BuOH fractions of MeOH extract of P. serpens L. show power activity against H460, HepG2, Hela, and PC9/GR cell lines, and no toxic effects against normal 16HBE cell lines. In our ongoing search for bioactive novel compounds from Chinese material medica, one new type of glycosylsphingolipids Psychotramide (1a-1c) were isolated from P. serpens L., and their structures were identified through spectroscopic techniques including NMR (1D and 2D) and MS (LC-MS, and GC-MS).

Keywords: Psychotria serpens L.; cytotoxic activity; glycosylsphingolipids.

MeSH terms

  • Cell Line
  • China
  • Gas Chromatography-Mass Spectrometry
  • Glycosphingolipids / chemistry
  • Glycosphingolipids / isolation & purification*
  • Glycosphingolipids / pharmacology
  • Humans
  • Medicine, Chinese Traditional
  • Molecular Structure
  • Psychotria / chemistry*
  • Spectrum Analysis

Substances

  • Glycosphingolipids